Elixir Software: Driving the Next Wave of Pharma R&D Excellence | #E33 - Voices of Pharma | Pharma Now

About this episode

Dr. Paul Faulder discusses how Elixir Software's iTRAX platform is transforming pharmaceutical R&D by addressing inefficiencies and enhancing collaboration.

📧 Can pharma research finally move beyond spreadsheets, emails, and chaos?Meet Dr. Paul Faulder, CEO & Co-founder of Elixir Software Ltd, the mind behind iTRAX, the cloud-based platform transforming pharmaceutical R&D into a connected, data-driven ecosystem.In this insightful Pharma Now Podcast, Dr. Paul shares how decades at AstraZeneca, GSK, and Amgen revealed the painful inefficiencies slowing down discovery. One missed email once cost an entire cancer project weeks of wasted synthesis, an experience that sparked the creation of ITRAX.💡 What You’ll Learn in This Episode: The origin story of Elixir Software and the development of iTRAX. Why pharma R&D struggles with data silos, communication gaps, and lost productivity. How the DMTA cycle can be accelerated through real-time visibility. How ITRAX unifies teams, CROs, and global sites into one collaborative digital workspace. Leadership insights from Dr. Paul on guiding teams through transformation. 🌐 iTRAX is more than software, it’s the operating system for pharmaceutical R&D.From bench scientists to global leaders, it brings live visibility, automated workflows, and actionable insights to every level of…

People in this episode

Host: Team Pharma Now

Guest: Dr. Paul Faulder

Topics covered

• pharmaceutical R&D
• data-driven ecosystem
• software solutions
• communication gaps
• productivity
• leadership insights

Keywords

• pharma research
• R&D excellence
• data silos
• real-time visibility
• automated workflows
• drug development

Mentioned in this episode

Organizations: Elixir Software Ltd, AstraZeneca, GSK, Amgen

Products: iTRAX